Anti-Human APP Abeta Recombinant Antibody(Solanezumab)
-
产品编号
YR1197
-
别名
科研级 Solanezumab ( 苏兰组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Solanezumab
-
规格
- 1mg
- 5mg
产品中心
Alias | 科研级 Solanezumab ( 苏兰组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Solanezumab |
Catalog Number | YR1197 |
Molecular Name | Solanezumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Solanezumab (proposed INN, LY2062430[1]) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector[2] for patients with Alzheimer's disease.[3][4] The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.[5] |
CAS Number | 955085-14-0 |
Application | WB, FuncS, IF, Neut, ELISA, FCM, IP |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | APP Abeta[Homo sapiens] |
销售微信
官方公众号